Free tool
Largest one day gains
The 50 largest one day percentage moves higher recorded at the latest close. The largest moves were BHVN at +17.9% and RHC.AX at +13.8%. By size, the list splits into 50 mid cap listings.
Switch view
All stocks50 of 23,178 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1D return | 1Y return |
|---|---|---|---|---|---|
| BHVN | Biohaven Ltd. | $2.56B | Mid cap | +17.87% | +8.65% |
| RHC.AX | Ramsay Health Care Limited | $8.56B | Mid cap | +13.79% | +50.95% |
| NANO.PA | Nanobiotix S.A. | $2.25B | Mid cap | +10.51% | +387.64% |
| ERAS | Erasca, Inc. | $6.70B | Mid cap | +7.83% | +1112.03% |
| AMBU-B.CO | Ambu A/S | $2.87B | Mid cap | +7.65% | −25.78% |
| SECT-B.ST | Sectra AB (publ) | $5.99B | Mid cap | +7.65% | −10.34% |
| NBTX | Nanobiotix S.A. | $2.26B | Mid cap | +7.20% | +394.99% |
| ZYME | Zymeworks Inc. | $2.10B | Mid cap | +6.68% | +96.28% |
| 008930.KS | Hanmi Science Co., Ltd. | $2.20B | Mid cap | +5.70% | +9.26% |
| XENE | Xenon Pharmaceuticals Inc. | $6.18B | Mid cap | +5.58% | +64.11% |
| VERA | Vera Therapeutics, Inc. | $2.65B | Mid cap | +4.37% | +67.21% |
| 2413.T | M3, Inc. | $7.76B | Mid cap | +4.30% | −13.96% |
| PVLA | Palvella Therapeutics, Inc. | $2.22B | Mid cap | +4.11% | +173.39% |
| KLRA | Kailera Therapeutics, Inc. | $2.39B | Mid cap | +3.89% | −29.08% |
| NEO | NeoGenomics, Inc. | $2.26B | Mid cap | +3.45% | +145.34% |
| ALIF-B.ST | AddLife AB (publ) | $2.15B | Mid cap | +3.32% | −4.16% |
| AXGN | AxoGen, Inc. Common Stock | $2.68B | Mid cap | +3.30% | +219.58% |
| WGS | GeneDx Holdings Corp. | $2.69B | Mid cap | +3.30% | −30.11% |
| ALMR | Alamar Biosciences, Inc. | $2.36B | Mid cap | +3.21% | +54.91% |
| KRK.WA | Krka, d. d. | $9.44B | Mid cap | +3.20% | +35.83% |
| BIOA-B.ST | BioArctic AB (publ) | $3.10B | Mid cap | +3.11% | +10.37% |
| GN.CO | GN Store Nord A/S | $2.19B | Mid cap | +3.11% | −16.23% |
| SRRK | Scholar Rock Holding Corporation | $7.31B | Mid cap | +3.07% | +74.18% |
| 4506.T | Sumitomo Pharma Co., Ltd. | $4.18B | Mid cap | +3.05% | −2.62% |
| CELC | Celcuity Inc. | $4.65B | Mid cap | +3.05% | +90.31% |
| ZEAL.CO | Zealand Pharma A/S | $3.39B | Mid cap | +3.05% | −25.81% |
| MMED | MiniMed Group, Inc. | $5.48B | Mid cap | +3.01% | +5.41% |
| CLOV | Clover Health Investments, Corp. | $2.26B | Mid cap | +2.91% | +57.99% |
| SRPT | Sarepta Therapeutics, Inc. | $2.06B | Mid cap | +2.85% | +7.69% |
| TNGX | Tango Therapeutics, Inc. | $4.29B | Mid cap | +2.83% | +269.13% |
| 000100.KS | Yuhan Corporation | $4.63B | Mid cap | +2.66% | −24.80% |
| RAPP | Rapport Therapeutics, Inc. | $2.52B | Mid cap | +2.60% | +250.70% |
| 9987.T | Suzuken Co., Ltd. | $2.19B | Mid cap | +2.44% | −9.81% |
| 3549.T | Kusuri No Aoki Holdings Co., Ltd. | $2.50B | Mid cap | +2.42% | +8.81% |
| ACHC | Acadia Healthcare Company, Inc. | $2.85B | Mid cap | +2.38% | +37.81% |
| ALHC | Alignment Healthcare, Inc. | $2.88B | Mid cap | +2.28% | −13.88% |
| HCM.L | HUTCHMED (China) Limited | $2.16B | Mid cap | +2.23% | −17.57% |
| LGND | Ligand Pharmaceuticals Incorporated | $5.74B | Mid cap | +2.18% | +80.92% |
| MSB.AX | Mesoblast Limited | $2.30B | Mid cap | +2.07% | +12.84% |
| PRGO | Perrigo Company plc | $2.05B | Mid cap | +1.93% | −36.05% |
| PGEN | Precigen, Inc. | $2.65B | Mid cap | +1.92% | +61.66% |
| MCOV-B.ST | Medicover AB (publ) | $3.92B | Mid cap | +1.86% | −6.91% |
| 6869.T | Sysmex Corporation | $7.42B | Mid cap | +1.82% | +7.21% |
| HRMY | Harmony Biosciences Holdings, Inc. | $2.31B | Mid cap | +1.82% | +4.23% |
| FIE.DE | Fielmann Group AG | $3.86B | Mid cap | +1.81% | −24.08% |
| 3088.T | MatsukiyoCocokara & Co. | $6.47B | Mid cap | +1.76% | −12.29% |
| ASKER.ST | Asker Healthcare Group AB (publ) | $3.04B | Mid cap | +1.75% | −20.70% |
| 4151.T | Kyowa Kirin Co., Ltd. | $8.74B | Mid cap | +1.74% | +5.98% |
| ANN.AX | Ansell Limited | $4.15B | Mid cap | +1.74% | +22.15% |
| OPCH | Option Care Health, Inc. | $3.60B | Mid cap | +1.69% | −15.91% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.
Micro and small cap listings are left out, so the list describes the market rather than thin trading, as are moves beyond 1,000% in a session, which are corporate actions the price series has not been restated for. This is a description of one day of price movement, nothing more. It says nothing about any company behind it.